2,402
Views
19
CrossRef citations to date
0
Altmetric
Research Paper

Antibody persistence after two vaccinations with either FSME-IMMUN® Junior or ENCEPUR® Children followed by third vaccination with FSME-IMMUN® Junior

, , , , , , , & show all
Pages 736-742 | Published online: 01 Jun 2012

References

  • Haglund M, Günther G. Tick-borne encephalitis--pathogenesis, clinical course and long-term follow-up. Vaccine 2003; 21:Suppl 1 S11 - 8; http://dx.doi.org/10.1016/S0264-410X(02)00811-3; PMID: 12628810
  • Lindquist L, Vapalahti O. Tick-borne encephalitis. Lancet 2008; 371:1861 - 71; http://dx.doi.org/10.1016/S0140-6736(08)60800-4; PMID: 18514730
  • Brauchli YB, Gittermann M, Michot M, Krähenbühl S, Gnehm HE. A fatal tick bite occurring during the course of tick-borne encephalitis vaccination. Pediatr Infect Dis J 2008; 27:363 - 5; http://dx.doi.org/10.1097/INF.0b013e318162a18e; PMID: 18316981
  • Schmolck H, Maritz E, Kletzin I, Korinthenberg R. Neurological, neuropsychological and electroencephalographic findings after European tick-borne encephalitis in children. J Child Neurol 2005; 20:506 - 8
  • Fritsch P, Gruber-Sedlmayr U, Pansi H, Zöhrer B, Mutz I, Spork D, et al. Tick-borne encephalitis in Styrian children from 1981 to 2005: a retrospective study and a review of the literature. Acta Paediatr 2008; 97:535 - 8; http://dx.doi.org/10.1111/j.1651-2227.2008.00763.x; PMID: 18394095
  • Logar M, Arnez M, Kolbl J, Avsic-Zupanc T, Strle F. Comparison of the epidemiological and clinical features of tick-borne encephalitis in children and adults. Infection 2000; 28:74 - 7; http://dx.doi.org/10.1007/s150100050050; PMID: 10782391
  • Loew-Baselli A, Poellabauer EM, Pavlova BG, Fritsch S, Firth C, Petermann R, et al. Prevention of tick-borne encephalitis by FSME-IMMUN vaccines: review of a clinical development programme. Vaccine 2011; 29:7307 - 19; http://dx.doi.org/10.1016/j.vaccine.2011.07.089; PMID: 21843576
  • Holbrook MR, Shope RE, Barrett AD. Use of recombinant E protein domain III-based enzyme-linked immunosorbent assays for differentiation of tick-borne encephalitis serocomplex flaviviruses from mosquito-borne flaviviruses. J Clin Microbiol 2004; 42:4101 - 10; http://dx.doi.org/10.1128/JCM.42.9.4101-4110.2004; PMID: 15364996
  • Ecker M, Allison SL, Meixner T, Heinz FX. Sequence analysis and genetic classification of tick-borne encephalitis viruses from Europe and Asia. J Gen Virol 1999; 80:179 - 85; PMID: 9934700
  • Bröker M, Schöndorf I. Are tick-borne encephalitis vaccines interchangeable?. Expert Rev Vaccines 2006; 5:461 - 6; http://dx.doi.org/10.1586/14760584.5.4.461; PMID: 16989626
  • Wittermann C, Schöndorf I, Gniel D. Antibody response following administration of two paediatric tick-borne encephalitis vaccines using two different vaccination schedules. Vaccine 2009; 27:1661 - 6; http://dx.doi.org/10.1016/j.vaccine.2008.10.003; PMID: 18940221
  • Wittermann C, Nicolay U, Hilbert AK, Schoendorf I. Paediatric tick-borne encephalitis (TBE) vaccines: schedules to optimize protection. Int J Med Microbiol 2008; 298:Suppl 1 301 - 4; http://dx.doi.org/10.1016/j.ijmm.2008.01.002
  • Pöllabauer EM, Pavlova BG, Löw-Baselli A, Fritsch S, Prymula R, Angermayr R, et al. Comparison of immunogenicity and safety between two paediatric TBE vaccines. Vaccine 2010; 28:4680 - 5; http://dx.doi.org/10.1016/j.vaccine.2010.04.047; PMID: 20433803
  • Barrett PN, Plotkin SA, Ehrlich H. Tick-borne encephalitis virus vaccine In: Plotkin SA, Orenstein WA, & Offit P, eds. Vaccines. Saunders Elsevier, 2008: 841 - 856.
  • Pöllabauer EM, Fritsch S, Pavlova BG, Löw-Baselli A, Firth C, Koska M, et al. Clinical evaluation to determine the appropriate paediatric formulation of a tick-borne encephalitis vaccine. Vaccine 2010; 28:4558 - 65; http://dx.doi.org/10.1016/j.vaccine.2010.04.075; PMID: 20452432
  • Holzmann H, Heinz FX, Mandl CW, Guirakhoo F, Kunz C. A single amino acid substitution in envelope protein E of tick-borne encephalitis virus leads to attenuation in the mouse model. J Virol 1990; 64:5156 - 9; PMID: 2398538
  • ICH-GCP guidelines. CPMP. 2002;
  • Declaration of Helsinki. 2004. World Medical Association. Available from: http://www.wma.net/e/ethicsunit/helsinki.htm
  • Adner N, Leibl H, Enzersberger O, Kirgios M, Wahlberg T. Pharmacokinetics of human tick-borne encephalitis virus antibody levels after injection with human tick-borne encephalitis immunoglobulin, solvent/detergent treated, FSME-BULIN S/D in healthy volunteers. Scand J Infect Dis 2001; 33:843 - 7; http://dx.doi.org/10.1080/00365540110027358; PMID: 11760166
  • Loew-Baselli A, Poellabauer EM, Pavlova BG, Fritsch S, Koska M, Bobrovsky R, et al. Seropersistence of tick-borne encephalitis antibodies, safety and booster response to FSME-IMMUN 0.5 ml in adults aged 18-67 years. Hum Vaccin 2009; 5:551 - 6; http://dx.doi.org/10.4161/hv.5.8.8571; PMID: 19430202
  • Kießig ST, Abler U, Risse P, Friedrich J, Heinz F, Kunz C. Problems of cut-off level determination in enzyme immunoassays: the case of TBE-ELISA. Klin Lab 1993; 11:877 - 86
  • Common Toxicity Criteria. Version 2.0, 30 April 1999. http://ctep.cancer.gov/protocolDevelopment/electronic_applications/docs/ctcv20_4-30-992.pdf.
  • Michael Marcy S, Kohl KS, Dagan R, Nalin D, Blum M, Jones MC, et al, Brighton Collaboration Fever Working Group. Fever as an adverse event following immunization: case definition and guidelines of data collection, analysis, and presentation. Vaccine 2004; 22:551 - 6; http://dx.doi.org/10.1016/j.vaccine.2003.09.007; PMID: 14741143

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.